Marshall Wace, LLP Prokidney Corp Ord Shs Cl A(Cy Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

Shares

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 14, 2024	BUY	$1.44 - $4.2 $72,348 - $211,016	50,242 New	50,242 $123,000
Q4 2023 Feb 14, 2024	BUY	$1.21 - $4.76 $28,193 - $110,908	23,300 New	23,300 $41,000
Q2 2022 Aug 15, 2022	BUY	$9.83 - $9.97 $7.24 Million - $7.35 Million	736,968 New	736,968 $7.33 Million

Others Institutions Holding PROK

# of Institutions

77

Shares Held

46.2M

Call Options Held

505K

Put Options Held

127K

Morgan Stanley New York, NY

14.3M
Shares

$24.1 Million
0.0% of portfolio
Suvretta Capital Management, LLC New York, NY

12.3M
Shares

$20.9 Million
0.93% of portfolio
Vanguard Group Inc Valley Forge, PA

5.22M
Shares

$8.81 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.66M
Shares

$6.18 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

2.2M
Shares

$3.72 Million
0.0% of portfolio

About PROKIDNEY CORP ORD SHS CL A(CY

Ticker PROK
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,540,200
Market Cap $104M

More about PROK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.